| 2023 | Association of Physical Activity With Risk of Liver Fibrosis , Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease | 유권; 김태헌; 김휘영; 이민종; 이혜아; 전호수 | Article |
| 2023 | Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis | 이한아 | Article |
| 2020 | Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study | 김휘영 | Article |
| 2022 | Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study | 이민종; 전호수 | Article |
| 2022 | Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | 김휘영 | Article |
| 2022 | Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease | 이하나 | Article |
| 2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | 이민종; 전호수 | Article |
| 2023 | Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future | 이한아 | Review |
| 2024 | PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B | 김태헌; 김휘영; 이민종; 이혜아; 전호수; 이한아 | Article |
| 2023 | Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease | 유권; 김태헌; 김휘영; 이민종; 이혜아; 전호수; 이한아 | Article |
| 2022 | Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases | 이한아 | Review |
